
Roberto Bolli MD
Adult Congenital Heart Disease
Professor, Medicine, University of Louisville School of Medicine
Join to View Full Profile
201 Abraham Flexner Way1001Louisville, KY 40202
Phone+1 502-587-4500
Fax+1 502-587-4146
Are you Dr. Bolli?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Roberto Bolli, MD is a cardiologist in Louisville, Kentucky. He is currently licensed to practice medicine in Kentucky and Texas. He is a Professor at University of Louisville School of Medicine.
Education & Training
- Baylor College of MedicineResidency, Internal Medicine, 1981 - 1983
- University of Perugia Faculty of MedicineClass of 1976
- Baylor College of MedicineFellowship, Cardiovascular Disease
Certifications & Licensure
- KY State Medical License 1995 - 2026
- TX State Medical License 1984 - 1995
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Intravenous infusions of mesenchymal stromal cells have cumulative beneficial effects in a porcine model of chronic ischaemic cardiomyopathy.Xian-Liang Tang, Marcin Wysoczynski, Anna M Gumpert, Mitesh Solanki, Yan Li
Cardiovascular Research. 2024-12-04 - CAESAR lives on with IMPACT: bringing rigor and relevance to cardioprotection research.Roberto Bolli, Xian-Liang Tang
Basic Research in Cardiology. 2024-12-01 - 3 citationsTrials and tribulations of cell therapy for heart failure: an update on ongoing trials.Jianyi Jay Zhang, Steven M Pogwizd, Keiichi Fukuda, Wolfram-Hubertus Zimmermann, Chengming Fan
Nature Reviews. Cardiology. 2024-11-15
Press Mentions
- Research Study at UofL First in US to Treat Heart Failure with Umbilical Cord Stem CellsDecember 24th, 2024
- Years After Brigham-Harvard Scandal, U.S. Pours Millions into Tainted Stem-Cell FieldJune 21st, 2022
- Cell Therapy Improves Outcomes for Heart Failure Patients, Clinical Trial ShowsJune 14th, 2021
- Join now to see all